OncoGenex Pharmaceuticals, Inc.
| Nasdaq: OGXI
OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company. It develops and commercializes new cancer therapies that address treatment resistance in cancer patients. The company has three product candidates in development: Custirsen, OGX-427 and OGX-225. OncoGenex Pharmaceuticals was founded by Martin E. Gleave and Scott Daniel Cormack in May 2000 and is headquartered in Bothell, WA.